These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8456326)

  • 41. Effect of stanozolol on factors VIII and IX and serum aminotransferases in haemophilia.
    Greer IA; Greaves M; Madhok R; McLoughlin K; Porter N; Lowe GD; Preston FE; Forbes CD
    Thromb Haemost; 1985 Jun; 53(3):386-9. PubMed ID: 3931287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improvements in accuracy and reproducibility of quantitative clotting factor assays by use of a novel approach for modeling reference curves.
    Givens TB; Fischer TJ; Callahan JB
    Comput Biol Med; 1994 Nov; 24(6):463-71. PubMed ID: 7789131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ["Lupus anticoagulant" in immune hyperthyroidism].
    Schuler G; Alexopoulos A; Hasler K; Kerp L
    Dtsch Med Wochenschr; 1990 Oct; 115(40):1511-4. PubMed ID: 2120025
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications].
    Allain JP
    Nouv Rev Fr Hematol; 1972; 12(2):241-9. PubMed ID: 4264617
    [No Abstract]   [Full Text] [Related]  

  • 45. A diffusable factor in Scottish coagulation factor concentrates can inhibit lymphocyte transformation in vitro.
    McDonald C; Jackson V; Kilpatrick DC; Yap PL; Prowse C
    Vox Sang; 1985; 49(3):187-94. PubMed ID: 3931352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Haemostatic abnormalities in canine Cushing's syndrome.
    Feldman BF; Rasedee A; Feldman EC
    Res Vet Sci; 1986 Sep; 41(2):228-30. PubMed ID: 3095898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factor VIII test in reference preparations: compensation for different dilutions.
    König H; Rosenkranz S; Nawrot R; Hunfeld A; Seitz R
    Pharmeur Sci Notes; 2005 Aug; 2005(1):11-3. PubMed ID: 17687888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of procoagulants produced in cell cultures by tests of coagulation.
    Zacharski LR; McIntyre OR
    Thromb Diath Haemorrh; 1971 Dec; 26(3):493-502. PubMed ID: 5144962
    [No Abstract]   [Full Text] [Related]  

  • 49. Standardization of Factors II, VII, IX and X in plasma and concentrates. Report of the ICTH Subcommittee on Factors VIII and IX, Brussels, July 1987.
    Barrowcliffe TW
    Thromb Haemost; 1988 Apr; 59(2):334. PubMed ID: 3388302
    [No Abstract]   [Full Text] [Related]  

  • 50. Fibronectin in blood products--an in vitro and in vivo study.
    Reilly JT; McVerry BA; Mackie MJ
    J Clin Pathol; 1983 Dec; 36(12):1377-81. PubMed ID: 6418769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Summary of work session 1: Blood coagulation in gastroenterology].
    Bredden K; Lechner K
    Z Gastroenterol; 1976 Mar; 14 Suppl():202-10. PubMed ID: 785839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative in vitro investigation of prothrombin complex concentrates.
    Römisch J; Bonik K; Müller HG
    Semin Thromb Hemost; 1998; 24(2):175-81. PubMed ID: 9579640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Occurrence of blood coagulation factors in situ in small cell carcinoma of the lung.
    Zacharski LR; Memoli VA; Rousseau SM; Kisiel W
    Cancer; 1987 Dec; 60(11):2675-81. PubMed ID: 2824013
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Standardization of assays of factor VIII and factor IX.
    Barrowcliffe TW
    Ric Clin Lab; 1990; 20(2):155-65. PubMed ID: 2115197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contribution of high factor VIII, IX and XI to the risk of recurrent venous thrombosis in factor V Leiden carriers.
    Lijfering WM; Christiansen SC; Rosendaal FR; Cannegieter SC
    J Thromb Haemost; 2009 Nov; 7(11):1944-6. PubMed ID: 19691477
    [No Abstract]   [Full Text] [Related]  

  • 56. Physical stability of cell culture procoagulants detectable in first-stage coagulation factor assays.
    Zacharski LR; McIntyre OR
    Proc Soc Exp Biol Med; 1972 Feb; 139(2):713-5. PubMed ID: 5059067
    [No Abstract]   [Full Text] [Related]  

  • 57. Problems in the standardization of Factor VIII assays.
    Kirkwood TB
    Scand J Haematol Suppl; 1980; 37():110-5. PubMed ID: 6787697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The values of synthetic substrates in the improvement of diagnostic tests for haemostatic function.
    Seghatchian J
    Ric Clin Lab; 1981; 11(1):11-25. PubMed ID: 6784230
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non Factor VIII related constituents in concentrates.
    Allain JP
    Scand J Haematol Suppl; 1984; 41():173-80. PubMed ID: 6440283
    [No Abstract]   [Full Text] [Related]  

  • 60. Clotting factor concentrates.
    Entwistle CC
    Int Anesthesiol Clin; 1985; 23(2):49-59. PubMed ID: 3924836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.